You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis

  • Technology appraisal guidance
  • Reference number: TA254
  • Published:  25 April 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Multiple sclerosis (relapsing-remitting) - fingolimod: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Multiple sclerosis (relapsing-remitting) - fingolimod: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) Multiple sclerosis (relapsing-remitting) - fingolimod: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
16 March 2012
(458.63 Kb 13 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 15 March 2012

Back to top